These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 34990589)
1. YAP1 and PRDM14 converge to promote cell survival and tumorigenesis. Kim M; Ly SH; Xie Y; Duronio GN; Ford-Roshon D; Hwang JH; Sulahian R; Rennhack JP; So J; Gjoerup O; Talamas JA; Grandclaudon M; Long HW; Doench JG; Sethi NS; Giannakis M; Hahn WC Dev Cell; 2022 Jan; 57(2):212-227.e8. PubMed ID: 34990589 [TBL] [Abstract][Full Text] [Related]
2. KRAS and YAP1 converge to regulate EMT and tumor survival. Shao DD; Xue W; Krall EB; Bhutkar A; Piccioni F; Wang X; Schinzel AC; Sood S; Rosenbluh J; Kim JW; Zwang Y; Roberts TM; Root DE; Jacks T; Hahn WC Cell; 2014 Jul; 158(1):171-84. PubMed ID: 24954536 [TBL] [Abstract][Full Text] [Related]
3. Blockade of a novel MAP4K4-LATS2-SASH1-YAP1 cascade inhibits tumorigenesis and metastasis in luminal breast cancer. Yang P; Li Y; Hou J; Wu D; Zeng X; Zeng Z; Zhang J; Xiong Y; Chen L; Yang D; Wan X; Wu Z; Jia L; Liu Q; Lu Q; Zou X; Fang W; Zeng X; Zhou D J Biol Chem; 2024 Jun; 300(6):107309. PubMed ID: 38657867 [TBL] [Abstract][Full Text] [Related]
4. YAP1-TEAD1-Glut1 axis dictates the oncogenic phenotypes of breast cancer cells by modulating glycolysis. Lin C; Xu X Biomed Pharmacother; 2017 Nov; 95():789-794. PubMed ID: 28892790 [TBL] [Abstract][Full Text] [Related]
5. Prostaglandin E Kim HB; Kim M; Park YS; Park I; Kim T; Yang SY; Cho CJ; Hwang D; Jung JH; Markowitz SD; Hwang SW; Yang SK; Lim DS; Myung SJ Gastroenterology; 2017 Feb; 152(3):616-630. PubMed ID: 27864128 [TBL] [Abstract][Full Text] [Related]
6. miR-375 is involved in Hippo pathway by targeting YAP1/TEAD4-CTGF axis in gastric carcinogenesis. Kang W; Huang T; Zhou Y; Zhang J; Lung RWM; Tong JHM; Chan AWH; Zhang B; Wong CC; Wu F; Dong Y; Wang S; Yang W; Pan Y; Chak WP; Cheung AHK; Pang JCS; Yu J; Cheng ASL; To KF Cell Death Dis; 2018 Jan; 9(2):92. PubMed ID: 29367737 [TBL] [Abstract][Full Text] [Related]
7. YAP1-induced RBM24 promotes the tumorigenesis of triple-negative breast cancer through the β-catenin pathway. Chen X; Lin X; Xia X; Xiang X J Investig Med; 2024 Jun; 72(5):403-413. PubMed ID: 38441112 [TBL] [Abstract][Full Text] [Related]
8. Honokiol Affects Stem Cell Viability by Suppressing Oncogenic YAP1 Function to Inhibit Colon Tumorigenesis. Subramaniam D; Ponnurangam S; Ramalingam S; Kwatra D; Dandawate P; Weir SJ; Umar S; Jensen RA; Anant S Cells; 2021 Jun; 10(7):. PubMed ID: 34206989 [TBL] [Abstract][Full Text] [Related]
9. TEAD4 promotes colorectal tumorigenesis via transcriptionally targeting YAP1. Tang JY; Yu CY; Bao YJ; Chen L; Chen J; Yang SL; Chen HY; Hong J; Fang JY Cell Cycle; 2018; 17(1):102-109. PubMed ID: 29157094 [TBL] [Abstract][Full Text] [Related]
10. ENO1 contributes to the gemcitabine resistance of pancreatic cancer through the YAP1 signaling pathway. Ma H; Kong L; Liu L; Du Y; Zhu X; Wang J; Zhao W Mol Carcinog; 2024 Jul; 63(7):1221-1234. PubMed ID: 38517039 [TBL] [Abstract][Full Text] [Related]
11. Hypoxia-inducible factor 2α (HIF-2α) promotes colon cancer growth by potentiating Yes-associated protein 1 (YAP1) activity. Ma X; Zhang H; Xue X; Shah YM J Biol Chem; 2017 Oct; 292(41):17046-17056. PubMed ID: 28848049 [TBL] [Abstract][Full Text] [Related]
12. Overexpression of transcription factor TBX5 inhibits the activation of YAP1-TEAD1 pathway to promote ferroptosis in lung cancer cells. Ma R; Hu K; Dai S; Wang Y Biochem Biophys Res Commun; 2024 Jul; 718():150037. PubMed ID: 38735135 [TBL] [Abstract][Full Text] [Related]
13. Mammalian Tead proteins regulate cell proliferation and contact inhibition as transcriptional mediators of Hippo signaling. Ota M; Sasaki H Development; 2008 Dec; 135(24):4059-69. PubMed ID: 19004856 [TBL] [Abstract][Full Text] [Related]
14. The transcription factor RUNX2 fuels YAP1 signaling and gastric cancer tumorigenesis. Guo Z; Zhou K; Wang Q; Huang Y; Ji J; Peng Y; Zhang X; Zheng T; Zhang Z; Chong D; Yang Z Cancer Sci; 2021 Sep; 112(9):3533-3544. PubMed ID: 34160112 [TBL] [Abstract][Full Text] [Related]
15. FGF18-FGFR2 signaling triggers the activation of c-Jun-YAP1 axis to promote carcinogenesis in a subgroup of gastric cancer patients and indicates translational potential. Zhang J; Wong CC; Leung KT; Wu F; Zhou Y; Tong JHM; Chan RCK; Li H; Wang Y; Yan H; Liu L; Wu WKK; Chan MWY; Cheng ASL; Yu J; Wong N; Lo KW; To KF; Kang W Oncogene; 2020 Oct; 39(43):6647-6663. PubMed ID: 32934314 [TBL] [Abstract][Full Text] [Related]
16. Mst1 and Mst2 protein kinases restrain intestinal stem cell proliferation and colonic tumorigenesis by inhibition of Yes-associated protein (Yap) overabundance. Zhou D; Zhang Y; Wu H; Barry E; Yin Y; Lawrence E; Dawson D; Willis JE; Markowitz SD; Camargo FD; Avruch J Proc Natl Acad Sci U S A; 2011 Dec; 108(49):E1312-20. PubMed ID: 22042863 [TBL] [Abstract][Full Text] [Related]
17. YAP1 and its fusion proteins in cancer initiation, progression and therapeutic resistance. Szulzewsky F; Holland EC; Vasioukhin V Dev Biol; 2021 Jul; 475():205-221. PubMed ID: 33428889 [TBL] [Abstract][Full Text] [Related]
19. YAP1 and TAZ Control Pancreatic Cancer Initiation in Mice by Direct Up-regulation of JAK-STAT3 Signaling. Gruber R; Panayiotou R; Nye E; Spencer-Dene B; Stamp G; Behrens A Gastroenterology; 2016 Sep; 151(3):526-39. PubMed ID: 27215660 [TBL] [Abstract][Full Text] [Related]
20. STUB1 suppresseses tumorigenesis and chemoresistance through antagonizing YAP1 signaling. Tang DE; Dai Y; Lin LW; Xu Y; Liu DZ; Hong XP; Jiang HW; Xu SH Cancer Sci; 2019 Oct; 110(10):3145-3156. PubMed ID: 31393050 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]